No abstract

Introduction: Human Immunodeficiency virus (HIV) is a virus that causes several diseases by attacking the human immune system. It is transmitted by contact with certain bodily fluids of an infected person, most commonly during unprotected sex, through sharing needles, or from mother to baby during pregnancy, birth or breastfeeding. The central nervous system is not spared from this virus, as HIV has been shown to induce several neurological disorders. However most neurological pathologies (such as dementia, infections, meningitis, and neuropathy) rarely show until late stages, in this case, after the patients develop acquired immunodeficiency syndrome (AIDS). This article aims to review the neurological disorders in the HIV population and the attempts initiated to limit the disease.Methodology: Data were collected from medical journals published on PubMed, Ovid MEDLINE, Science Direct and Embase bibliographical databases with a predefined search strategy. All articles considering neurological disorders associated with HIV were considered. Results: To date, the pathogenesis of HIV-associated neurological complications remains poorly elucidated; thus, imposing a hindrance and limitations on the treatment options. Nevertheless, some studies have reported alterations in dendritic spine as the causative agent for developing brain damage. Conclusion:HIV remains one of the most serious global health challenges, with neurological manifestations imposing a major concern among patients with HIV. Despite the availability and efficacy of antiretroviral therapies, yet, the risk of developing neurological complications remains relatively high among patients with HIV. Thus, the 2030 HIV vision must focus on further preventive measures to protect HIV patients from developing such neurological complications.

BackgroundPatients are increasingly using YouTube™ as a source of information on Breast cancer, the most frequent cancer among women. Educating patients is highly important to reduce mortality rates. This study aims to evaluate, for the rst time, Breast Cancer Videos on YouTube™ in the Arab world that hosts their highest use. MethodsIn this cross-sectional study, the most viewed 60 videos were evaluated for global quality (GQS score), reliability (modi ed DISCERN score), usefulness (content-speci c score), and misleading claims. Videos' power index, popularity, duration, and viewers' interaction were assessed. Sources (professional/ nonprofessional) and speakers (physician/ non-physician) were categorized. ResultsThe median Global Quality (3/5), Reliability (2/5), and Usefulness scores (4/11) were overall low. Out of all videos, the speaker was a physician in 32% and misleading information was found in 42%. Although professional source videos (45%) were less viewed, they were less misleading, of higher quality, reliability, and usefulness than non-professional source videos (55%). Source categories did not affect viewers' interaction, video power index, nor duration. While Symptoms (55%) were discussed the most, genetic counseling (13%) and prevention (20%) were scarcely mentioned; professionals were more likely to highlight early diagnosis importance. ConclusionsYouTube™ is poorly informational on breast cancer and may be inaccurate in the Arab world where highly used. Although professional uploaders' videos tend to be more adequate, they are of lower quantity and popularity. Governments and physicians should upload more intelligibly informational videos, guide the public for accurate sources, and encourage regulations.

No abstract